What is the rating for CCRN stock?

CROSS COUNTRY HEALTHCARE INC (CCRN) has a "Reduce" rating based on our 6-factor quantitative model. It has a composite score of 43.9 and ranks #2984 out of 7,333 stocks in our coverage universe with a 2-star rating.

Is CCRN a good stock to buy?

Based on our quantitative analysis, CCRN receives a "Reduce" rating with 2 out of 5 stars. Key factors include: Quality score of 41.2, Value score of 43.1, and Momentum score of 23.6. The timing score is 53, indicating "Neutral" entry conditions. This is not investment advice - please conduct your own research.

What sector is CCRN in?

CROSS COUNTRY HEALTHCARE INC (CCRN) operates in the Services sector, specifically in the Business Services industry. It has a market capitalization of $0.47 billion.

What is CCRN's P/E ratio?

P/E ratio data is not currently available for CCRN.

Does CCRN pay a dividend?

CCRN does not currently pay a dividend.

What is CCRN's market cap?

CROSS COUNTRY HEALTHCARE INC (CCRN) has a market capitalization of $0.47 billion, making it a small-cap stock.

What are the risks of investing in CCRN?

Key risk factors for CCRN include: and general market risk. As with all investments, there is risk of loss.

How does CCRN compare to peers?

Within the Services sector, CCRN ranks #2984 overall with a quality score of 41.2/100 and value score of 43.1/100.

What is CCRN's revenue growth?

CCRN has revenue growth of -26.4% year-over-year.

What is CCRN's composite score?

CROSS COUNTRY HEALTHCARE INC (CCRN) has a composite score of 43.9/100, which places it at rank #2984 out of 7,333 stocks. This score is derived from our proprietary 6-factor quantitative model that evaluates quality, value, momentum, investment efficiency, stability, and short interest.

How does CCRN compare to the S&P 500?

CCRN ranks in the top 59% of all stocks in our coverage universe with a composite score of 43.9.

What are the bull and bear cases for CCRN?

Bull case: CCRN scores highest in stability at 73.9/100, indicating strong performance in this area. Bear case: The weakest factor is momentum at 23.6/100, which may present a risk. Our overall assessment is Reduce with 2 out of 5 stars.

Is CCRN overvalued or undervalued?

CCRN appears fairly valued with a value factor score of 43.1/100.

What is CCRN's momentum score?

CCRN has a momentum score of 23.6/100, placing it in the weak category. This suggests recent price weakness and potential selling pressure.

When is CCRN's next earnings date?

For the latest earnings date and analysis for CCRN, visit our earnings calendar or check the CCRN stock page for real-time updates. Our AI-generated earnings reports provide in-depth analysis after each quarterly report.

Is CCRN a good stock to buy right now?

Based on our 6-factor quantitative model, CROSS COUNTRY HEALTHCARE INC (CCRN) receives a "Reduce" rating with a composite score of 43.9/100. It is ranked #2984 out of 7,333 stocks. Key factor scores: Quality 41/100, Value 43/100, Momentum 24/100. The timing signal is "Neutral". This is quantitative analysis only — not investment advice.

What is the stock rating for CCRN?

CROSS COUNTRY HEALTHCARE INC (CCRN) has a "Reduce" rating and 2-star score. The composite score of 43.9 ranks it #2984 among 7,333 U.S. stocks. Ratings are updated weekly using academically-proven factor models.

What sector is CCRN in?

CROSS COUNTRY HEALTHCARE INC operates in the Services sector (Business Services industry) with a market cap of $465 million. It is classified as a small-cap stock.

Does CCRN pay a dividend?

CCRN does not currently pay a regular dividend. The company may be reinvesting profits for growth.

What is CCRN's P/E ratio?

P/E ratio data is not currently available for CCRN, which may indicate the company is not yet profitable.

How profitable is CCRN?

CCRN's quality factor score is 41/100. Gross margin: 20.3%. ROE: -2.3% vs sector average 5.7%. Margins are moderate to low, reflecting competitive market dynamics.

How is CCRN valued compared to peers?

CCRN's value factor score is 43/100 (higher = cheaper). Key multiples: . Valuation is roughly in line with peers.

What is CCRN's debt level?

CCRN's debt-to-equity ratio is 32%. Sector average: 0%. Low leverage suggests conservative financial management.

CCRN has a beta of 0.40, meaning it is less volatile than the market. Stability score: 74/100.

Does CCRN have high short interest?

CCRN's short interest factor score is 56/100 (higher = less short selling). Moderate short interest.

CCRN Stock Analysis — CROSS COUNTRY HEALTHCARE INC Price Target & Forecast 2026

IMPORTANT DISCLAIMER: Blank Capital Research ("BCR") is a technology platform, not a registered investment advisor or broker-dealer. The algorithmically generated signals, scores, and rankings provided on this site ("God Mode" Signals) are for informational and research purposes only and do not constitute financial advice, investment recommendations, or an offer to sell or solicit an offer to buy any securities.

HYPOTHETICAL PERFORMANCE RESULTS: The "timing scores" and "regime signals" displayed are based on quantitative models. Hypothetical or simulated performance results have certain inherent limitations. Unlike an actual performance record, simulated results do not represent actual trading. Also, since the trades have not actually been executed, the results may have under-or-over compensated for the impact, if any, of certain market factors, such as lack of liquidity.

RISK OF LOSS: Trading in financial markets involves a high degree of risk and may result in the loss of your entire investment. Data provided by third-party sources (Intrinio, Snowflake) is believed to be reliable but is not guaranteed for accuracy or completeness. Past performance is not indicative of future results.

CCRN Stock Analysis — CROSS COUNTRY HEALTHCARE INC Price Target & Forecast 2026 | Blank Capital Research

Sector

Services

Industry

Business Services

Market Cap

$465M

Leadership

John A. Martins

Business Summary

Cross Country Healthcare, Inc. provides talent management and other consultative services for healthcare clients in the United States. The Nurse and Allied Staffing segment offers traditional staffing, including temporary and permanent placement of travel nurses and allied professionals, local nurses, and allied staffing. This segment provides physicians in various specialties, certified registered nurse anesthetists, nurse practitioners, and physician assistants under the Cross Country Locums brand.

Operations

Headcount

2.7K

Location

HQ Base

BOCA RATON, Florida

Fundamental Spot Check

Context: 2025

Valuation

Market Cap

$465M

P/E Ratio

P/B Ratio

0.69xOutperforming

P/S Ratio

0.25xOutperforming

EV/EBITDA

Dividend Yield

0.00%

Efficiency & Risk

Gross Margin

20.3%Lagging

Operating Margin

-1.0%Lagging

ROE

-2.3%Lagging

Rev Growth (YoY)

-26.4%

Debt/Equity

32.00xLagging

Beta

0.40

Red = Sector Laggard

Black = Market Average

Revenue Breakdown

Strategic Timing Audit

WEAK

1/6

Mixed Alignment [1 BULL / 2 BEAR]

Quantitative Factor Convergence Analysis Verified

Momentum

24th pctl

Intelligence Feed

yahooYesterday Neutral

Cross Country Healthcare to Attend the Truist Securities Virtual Human Capital Conference and the Oppenheimer 36th Annual Healthcare Medtech & Services Conference

BOCA RATON, Fla., February 23, 2026--Cross Country Healthcare, Inc. (the "Company") (Nasdaq: CCRN) announced today that it is scheduled to participate in two upcoming conferences:

BenzingaDec 4 Negative

Cross Country Healthcare Agrees To Be Acquired By Aya Healthcare, Shareholders To Receive 67% Premium

Cross Country Healthcare has agreed to be acquired by Aya Healthcare for $18.61 per share, a 67% premium over the previous closing price. The merger will expand Aya's services and provide growth opportunities for employees.

BenzingaMay 2 Neutral

A Glimpse Into The Expert Outlook On Cross Country Healthcare Through 4 Analysts

Throughout the last three months, 4 analysts have evaluated Cross Country Healthcare (NASDAQ:CCRN), offering a diverse set of opinions from bullish to bearish. The following table provides a quick overview of their recent ratings, highlighting the changing sentiments over the past 30 days and comparing them to the preceding months. Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 2 1 1 0 0 Last 30D 1 0 0 0 0 1M Ago 0 0 0 0 0 2M Ago 0 0 0 0 0 3M Ago 1 1 1 0 0 Insights from analysts' 12-month price targets are revealed, presenting an average target of $20.0, a high estimate of $24.00, and a low estimate of $16.00. This current average has decreased by 13.98% from the previous average price target of $23.25. Interpreting Analyst Ratings: A Closer Look A clear picture of Cross Country Healthcare's perception among financial experts is painted with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets. Analyst Analyst Firm Action Taken Rating Current Price Target Prior Price Target Bill Sutherland Benchmark Lowers Buy $19.00 $21.00 Kevin Steinke Barrington Research Lowers Outperform $24.00 $26.00 Tobey Sommer Truist Securities Lowers Hold $16.00 $22.00 Bill Sutherland Benchmark Lowers Buy $21.00 $24.00 Key Insights: Action Taken: Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Cross Country Healthcare. This information offers a snapshot of how analysts perceive the current state ...Full story available on Benzinga.com

Zacks Investment ResearchJun 28 Neutral

Do Options Traders Know Something About Cross Country Healthcare (CCRN) Stock We Don't?

Investors need to pay close attention to Cross Country Healthcare (CCRN) stock based on the movements in the options market lately.

zacks.com6d ago Neutral

TrueBlue (TBI) Reports Q4 Loss, Beats Revenue Estimates

Earnings Call Transcripts

Unlock Valuation Tools

Get full access to institutional-quality research tools with Blank Capital Pro.

Upgrade to Pro

Starting at $19.99/mo

Financial Intelligence Ledger

Verified SEC Filings Aggregate • CCRN

Export

Metric Entity	10Y Historical Trend	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Revenue		$1.3B33.5%	$2.0B28.0%	$2.8B67.4%	$1.7B100.5%	$836M1.7%	$822M0.7%	$816M5.6%	$865M3.8%	$834M8.6%	$767M
Cost of Revenue		$1.1B31.8%	$1.6B28.0%	$2.2B67.4%	$1.3B	$3M51.1%	$2M8.9%	$2M20.6%	$2M208.3%	$593K99.9%	$571M
Gross Profit		$274M39.1%	$450M28.2%	$628M67.4%	$375M55.0%	$833M1.6%	$820M0.7%	$814M5.7%	$863M3.6%	$833M324.2%	$196M
R&D Expense	-	—	—	—	—	—	—	—	—	—	—
Operating Expenses		$291M13.8%	$338M4.8%	$355M50.4%	$236M72.0%	$843M0.8%	$836M1.1%	$827M2.9%	$851M3.0%	$827M370.3%	$176M
Operating Income		-$17M115.0%	$113M58.7%	$273M96.1%	$139M	-$9M41.7%	-$16M22.0%	-$13M209.6%	$12M90.0%	$6M69.9%	$21M
Interest Expense		—	$8M43.8%	$14M109.6%	$7M137.6%	$3M60.3%	$7M27.1%	$6M37.6%	$9M19.7%	$8M12.7%	$7M
Tax Provision		-$2M106.1%	$30M55.4%	$68M	$1M741.5%	-$188K100.6%	$32M	-$2M92.8%	-$35M724.2%	-$4M427.2%	-$794K
EBITDA		-$17M115.0%	$113M58.7%	$273M96.1%	$139M	$3M213.3%	-$3M318.2%	-$682K102.8%	$24M5.1%	$23M10.5%	$21M
Net Income		-$15M120.0%	$73M61.5%	$188M42.8%	$132M	-$12M78.3%	-$56M255.9%	-$16M140.5%	$39M344.4%	$9M76.2%	$5M
EPS (Diluted)		$-0.44121.3%	$2.0759.3%	$5.0941.4%	$3.60	$-0.3677.6%	$-1.61235.4%	$-0.48144.9%	$1.07328.0%	$0.2578.6%	$0.14

SEC EDGAR Repository

Direct unfiltered access to 10-K, 10-Q and 8-K filings for CCRN.

Open Regulatory Dossier

Data Integrity Notice

Figures adjusted for stock splits and restatements where applicable.

TTM (Trailing Twelve Months) data updates within 48 hours of quarterly filings.

Execution Benchmarks Audit

Revenue Growth

YOY expansion rate

-408% SCTR

-26.4%

Sector Avg: 8.6%

Gross Margin

Core pricing power

-69% SCTR

20.3%

Sector Avg: 64.6%

Operating Margin

Operating efficiency

-122% SCTR

-1.0%

Sector Avg: 4.5%

Return on Equity

Equity efficiency

-140% SCTR

-2.3%

Sector Avg: 5.7%

Debt/Equity

Financial leverage

-9043% SCTR

32.0%

Sector Avg: 0.3%

Dividend Yield

Direct cash return

-NaN% SCTR

0.0%

Sector Avg: 0.0%

Financial History

Forensic Accounting Audit

Audit Required

Asset Efficiencymedium RISK

Material decline in asset turnover efficiency detected

Margin Integritymedium RISK

High margin volatility — erratic forensic earnings quality

Algorithmic red flag detection based on regulatory SEC filings.

Unlock Financial Statements

Get full access to institutional-quality research tools with Blank Capital Pro.

Upgrade to Pro

Starting at $19.99/mo

Shareholder Returns

Capital Allocation audit

Smart Money Conviction

Neutral

Synthesized from recent 13F filings, Form 4 insider transactions, and outstanding short interest metrics.

Governance Audit

Moderate Index

WeakModerateStrong

Average governance indicators based on financial metrics. Verified against factor-based integrity benchmarks.

Executive Operations

CEO: John A. Martins

Insider alignment Audit

No recent insider transactions available for CCRN

Major Institutional Blocks

Top 5 Holders

Institutional cap table data requires verified 13F filing feeds.

Access SEC 13F Dossier →

Form 4 Filings

Recent Activity

Insider transaction data currently awaiting regulatory verification.

Access SEC Form 4 Dossier →

Regulatory Disclosure Vault

Proxy Statement (DEF 14A)

Exec Comp, Board Nominees, Proposals

Annual Report (10-K)

MD&A, Risk Factors, Strategy

Institutional Holders (13F)

Loading institutional data...

Insider Liquidity

Unlock Governance & Ownership

Get full access to institutional-quality research tools with Blank Capital Pro.

Upgrade to Pro

Starting at $19.99/mo

Unlock Factor Analysis

Get full access to institutional-quality research tools with Blank Capital Pro.

Upgrade to Pro

Starting at $19.99/mo

Unlock Investment Thesis

Get full access to institutional-quality research tools with Blank Capital Pro.

Upgrade to Pro

Starting at $19.99/mo

Institutional Peer Matrix

Top Services Universe

Factor Alpha Dispersion: Value vs. Quality

Quadrant I: High Quality / Undervalued

Quadrant III: Low Quality / Expensive

X-AXIS: EV/EBITDA (LOWER = CHEAPER) | Y-AXIS: ROE (HIGHER = ELITE) | RED CIRCLE = CCRN ANALYSIS TARGET

Stock	Rating	Score▼	Quality	Value	Momentum	P/E	EV/EBITDA	ROE	ROA	Gross Mgn	Op Mgn	Net Mgn	Rev Growth	Div Yield	D/E	Mkt Cap	AUDIT
$YALA Yalla Group Ltd		75	89	99	80	-	-	-	-	-	-	-	-	-	-	$0	VS
$GRVY GRAVITY Co., Ltd.		75	82	96	71	-	-	-	-	-	-	-	-	-	-	$0	VS
$ISSC INNOVATIVE SOLUTIONS & SUPPORT INC		73	81	88	94	25.0x	14.1x	17.1%	10.3%	35.5%	14.6%	10.1%	105.2%	0.0%	41.0x	$244M	VS
$AER AerCap Holdings N.V.		72	60	87	84	-	-	-	-	-	-	-	-	-	-	$0	VS
$HCSG HEALTHCARE SERVICES GROUP INC		72	74	88	88	7.1x	6.1x	28.9%	20.8%	20.8%	9.9%	9.3%	8.5%	0.0%	1.0x	$1.2B	VS
$LQDT LIQUIDITY SERVICES INC		72	90	88	68	24.9x	14.3x	14.1%	8.3%	45.7%	8.5%	6.2%	28.1%	0.0%	0.0x	$736M	VS
$TRTNpA Triton International Ltd		71	70	89	70	-	1.7x	0.0%	-	97.4%	58.0%	37.4%	-	8.8%	264.0x	$2.5B	VS
$EDU New Oriental Education & Technology Group Inc.		71	83	52	77	-	-	-	-	-	-	-	-	-	-	$0	VS
$NTES NetEase, Inc.		71	88	93	68	-	-	-	-	-	-	-	-	-	-	$0	VS
$UTI UNIVERSAL TECHNICAL INSTITUTE INC		70	86	86	72	43.2x	16.0x	15.3%	5.8%	100.0%	6.9%	5.2%	15.1%	0.0%	24.0x	$1.8B	VS
$CCRN CROSS COUNTRY HEALTHCARE INC		44	41	43	24	-	-	-2.3%	-1.7%	20.3%	-1.0%	-0.9%	-26.4%	0.0%	32.0x	$465M
SECTOR BENCH	-	-	-	-	-	23.7x	11.7x	5.7%	2.4%	64.6%	4.5%	2.8%	8.6%	0.0%	0.3x	-	REF

Access Full Services Intelligence Archive →

Lateral Comparison Mesh

$CCRN / $YALA AUDIT $CCRN / $GRVY AUDIT $CCRN / $ISSC AUDIT $CCRN / $AER AUDIT $CCRN / $HCSG AUDIT

Market Intelligence FAQ

CROSS COUNTRY HEALTHCARE INC (CCRN) receives a "Reduce" rating with a composite score of 43.9/100. It ranks #2984 out of 7,333 stocks in our coverage universe and carries a 2-star rating. Ratings are driven by a 6-factor quantitative model measuring quality, value, momentum, investment, stability, and short interest.

Full Research Publication

Equity Research Analysis: CROSS COUNTRY HEALTHCARE INC (CCRN)

FEBRUARY 2026|Blank Capital Research Unit|Spot: $8.74

Price$8.74

Composite Score43.9/100

RatingREDUCE (2★)

Rank#2984 OF 7,333

Market Cap$465M

Comments

Institutional Audit

Feb 25, 2026

CROSS COUNTRY HEALTHCARE INC

43.9

Sector Decomposition auditServices [N=802]

Factor	Global	Sector	Tilt
PROFITABILITY	41	37	+4NEUTRAL
MOMENTUM	24	17	+7ALPHA
VALUATION	43	42	+1NEUTRAL
INVESTMENT	35	55	-20DRAG
STABILITY	74	80	-6DRAG
SHORT INT	56	71	-15DRAG

Global = full universe. Sector = relative to industry peers. Positive tilt indicates idiosyncratic strength.

Executive Summary

CROSS COUNTRY HEALTHCARE INC receives a Reduce rating from our analysis, with a composite score of 43.9/100 and 2 out of 5 stars, ranking #2984 out of 7,333 stocks. CCRN's factor profile shows weakness across multiple dimensions, suggesting the stock may underperform going forward. Existing holders may want to consider trimming positions or tightening stop-losses.

Business Quality

CCRN's quality score of 41/100 is below average, suggesting challenges with profitability or capital efficiency. The company reports a return on equity of -2.3% (sector avg: 5.7%), gross margins of 20.3% (sector avg: 64.6%), net margins of -0.9% (sector avg: 2.8%). Investors should examine whether management is actively addressing these weaknesses or if they reflect structural industry headwinds.

Intrinsic Valuation

With a value score of 43/100, CCRN appears somewhat expensive relative to its fundamentals. Key valuation metrics include a P/B ratio of 0.69x. Investors paying a premium here are likely betting on above-average growth or margin expansion to justify current prices.

Capital Reinvestment

CROSS COUNTRY HEALTHCARE INC's investment score of 35/100 suggests limited reinvestment activity. Key growth metrics include revenue growth of -26.4% vs. a sector average of 8.6% and a return on assets of -1.7% (sector: 2.4%). While this can be positive for mature, cash-generative businesses returning capital to shareholders, it may also signal a lack of growth opportunities or management conservatism.

Market Momentum

CROSS COUNTRY HEALTHCARE INC is experiencing notably weak momentum with a score of just 24/100. The stock has underperformed its peers and is trending below major moving averages. Revenue growth stands at -26.4% year-over-year, while a beta of 0.40 reflects its sensitivity to broader market moves. While deep momentum weakness can occasionally present value opportunities, it often reflects deteriorating fundamentals or structural headwinds that may persist.

Balance Sheet Health

CCRN shows good financial stability with a score of 74/100. Key stability metrics include a beta of 0.40 and a debt-to-equity ratio of 32.00x (sector avg: 0.3x). This suggests manageable leverage and moderate price volatility, making it appropriate for investors seeking a balance between growth potential and capital preservation.

Institutional Risk Profile

The short interest score of 56/100 for CCRN suggests somewhat elevated bearish positioning by institutional traders. Specific risk factors include elevated leverage (D/E: 32.00x), small-cap liquidity risk. With a $465M market cap (small-cap), CROSS COUNTRY HEALTHCARE INC may experience above-average volatility. Investors should consider whether the short thesis has merit or if it creates a potential short-squeeze opportunity.

Sector Benchmark Analysis

CROSS COUNTRY HEALTHCARE INC is a small-cap company in the Services sector, ranked #0 of 50 in its sector (100th percentile) and #2984 of 7,333 overall (59th percentile). Key comparisons include ROE of -2.3% trailing the 5.7% sector median and operating margins of -1.0% below the 4.5% sector average. This top-quartile standing reflects exceptional competitive strength relative to Services peers.

Comparative Research Mesh

CCRN VS S&P 500 (SPY)TOP SERVICES PEERS

Strategic Alternatives

While CCRN currently exhibits a REDUCE profile, superior opportunities exist within the SERVICES sector. Our model identifies several "Strong Buy" candidates with higher quality scores and more attractive valuations among direct industry competitors.

View Top Services Alpha →

CCRN

CROSS COUNTRY HEALTHCARE INC

Business Summary

Operations

Location

Fundamental Spot Check

Valuation

Efficiency & Risk

Intelligence Feed

Cross Country Healthcare to Attend the Truist Securities Virtual Human Capital Conference and the Oppenheimer 36th Annual Healthcare Medtech & Services Conference

Cross Country Healthcare Agrees To Be Acquired By Aya Healthcare, Shareholders To Receive 67% Premium

A Glimpse Into The Expert Outlook On Cross Country Healthcare Through 4 Analysts

Do Options Traders Know Something About Cross Country Healthcare (CCRN) Stock We Don't?

TrueBlue (TBI) Reports Q4 Loss, Beats Revenue Estimates

Unlock Valuation Tools

Unlock Financial Statements

Unlock Governance & Ownership

Unlock Factor Analysis

Unlock Investment Thesis

Factor Alpha Dispersion: Value vs. Quality

Lateral Comparison Mesh

Comments

Unlock Performance & Technicals

SEC Risk Factors

Economic Moat Audit

Economic Value Creation

Margin Superiority

Reinvestment Efficiency

Growth Durability

Financial Resilience

Uncertainty Audit

BEAR THESIS

01Executive Summary

02Strategy & Outlook

Risk / Reward Variance

Research Verdict

Related Stocks

Executive Summary

Business Quality

Intrinsic Valuation

Capital Reinvestment

Market Momentum

Balance Sheet Health

Institutional Risk Profile

Sector Benchmark Analysis

Comparative Research Mesh

Strategic Alternatives

Factor Dispersion Audit

Sector Variance Findings

Market Intel

Intelligence Feed

Cross Country Healthcare to Attend the Truist Securities Virtual Human Capital Conference and the Oppenheimer 36th Annual Healthcare Medtech & Services Conference

Cross Country Healthcare Agrees To Be Acquired By Aya Healthcare, Shareholders To Receive 67% Premium

A Glimpse Into The Expert Outlook On Cross Country Healthcare Through 4 Analysts

Do Options Traders Know Something About Cross Country Healthcare (CCRN) Stock We Don't?

TrueBlue (TBI) Reports Q4 Loss, Beats Revenue Estimates